IOVA

NASD Iovance Biotherapeutics Inc
Oct 12, 2026 · 8:25 AM ET LAST TRADE Market Closed

$14.60 ↓ -0.02 (-0.14%) Trading Down from the previous close of $14.62

YTD change
+434.80%
vs 20-day SMA
+22.57%
vs 200-day SMA
+191.45%

Price ranges

Previous day
$13.29 $14.94
open $13.36 close $14.62
+$1.26 (+9.43%)
Today
$0.00 $0.00
$14.60
Past week
$12.31 $14.94
from $14.22 now $14.60
+$0.39 (+2.71%)
Past month
$8.54 $15.30
from $8.60 now $14.60
+$6.00 (+69.77%)
This year
$2.21 $15.30
from $2.73 now $14.60
+$11.87 (+434.80%)

Price & Performance

+11.16 (+322.54%) / 6M

$2.39$6.84$11.29$15.74Apr 13Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 73.1% away from all-time highs of $54.21
  • IOVA is up 435% since the beginning of the year
  • IOVA is up 595% over the past 12 months
  • IOVA is up 70% over the past 1 month
  • 22% of all IOVA investors are betting against IOVA

IOVA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +583.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.11
Earnings momentum -27.8% Quarterly EPS growth
Quarterly change -27.8%

Valuation

P/E ratio N/A
Enterprise value $6.3B
Beta 1.80

Balance sheet & scale

IncomeN/A
Revenue$325.0M
Cash$297.7M
Debt$46.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $6.6B

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $32.21 +2.17%
ARGX argenx SE Sponsored ADR $825.03 +0.78%
ONC BeOne Medicines Ltd. Sponsored ADR $354.47 +1.24%
WXIBF Wuxi Biologics (Cayman) Inc. $7.29 +1.67%
INCY Incyte Corporation $112.79 +0.04%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.